Ibucaps (Ibuprofen)

Ibuprofen blocks the activity of COX‑1 and COX‑2 enzymes, which are needed to produce prostaglandins. By lowering prostaglandin levels, it reduces the signals that cause pain, fever, and inflammation at the affected site.

The appropriate dose of Ibucaps is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety of ibuprofen in pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only if the benefit outweighs the risk. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the Ibucaps product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibucaps (ibuprofen) offers a balanced profile of analgesic, antipyretic and anti‑inflammatory effects with a relatively short half‑life, allowing flexible dosing. Compared with naproxen, it may have a quicker onset but may require more frequent dosing; compared with aspirin, it has less impact on platelet function.

Ibucaps should be stored at ambient temperature, preferably below 25 °C. Keep the capsules in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Ibucaps are taken orally with a full glass of water. They may be taken with or without food; taking them with food can help reduce gastrointestinal discomfort. Swallow the capsule whole; do not crush or chew.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment especially in patients with pre‑existing kidney disease, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience these symptoms.

Ibucaps should be avoided by individuals with a known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers or bleeding, patients with severe renal or hepatic impairment, and anyone in the third trimester of pregnancy unless specifically advised by a physician.